CHECK POINT SOFTWARE TO ANNOUNCE FIRST QUARTER 2020 FINANCIAL RESULTS ON APRIL 27, 2020
SAN CARLOS, Calif., April 03, 2020 (GLOBE NEWSWIRE) — Check Point® Software Technologies Ltd. (NASDAQ: CHKP), a leading provider of […]
Retail Opportunity Investments Corp. Withdraws 2020 FFO Guidance
SAN DIEGO, April 03, 2020 (GLOBE NEWSWIRE) — In light of the ongoing COVID-19 pandemic, Retail Opportunity Investments Corp. (NASDAQ: […]
Emclaire Financial Corp to hold Annual Meeting of Shareholders Virtually
EMLENTON, Pa., April 03, 2020 (GLOBE NEWSWIRE) — Emclaire Financial Corp (NASDAQ:EMCF), the parent holding company of The Farmers National […]
Voyager Therapeutics Provides Update on the RESTORE-1 Parkinson’s Disease Trial
CAMBRIDGE, Mass., April 03, 2020 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on […]
iClick Featured in Broadcast on Acceleration of Online Marketing in China
NEW YORK, April 03, 2020 (GLOBE NEWSWIRE) — via NetworkNewsAudio – iClick Interactive Asia Group (NASDAQ:ICLK)Bay Street News
Trxade Featured in Broadcast on Much-Needed Solutions to Healthcare Dilemma
NEW YORK, April 03, 2020 (GLOBE NEWSWIRE) — via NetworkNewsAudio – Trxade Group Inc. (NASDAQ: MEDS) announces the availability of a […]
Kaleido Biosciences Appoints Anne Prener, M.D., Ph.D., to its Board of Directors
LEXINGTON, Mass., April 03, 2020 (GLOBE NEWSWIRE) — Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven […]
La Jolla Pharmaceutical Company to Provide GIAPREZA™ (Angiotensin II) for Named Patient Emergency Use in Patients with Septic Shock Due to COVID-19 at University Hospital Frankfurt in Germany
SAN DIEGO, April 03, 2020 (GLOBE NEWSWIRE) — La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development […]
Manhattan Associates Provides Corporate Update in Response to COVID-19
ATLANTA, April 03, 2020 (GLOBE NEWSWIRE) — Manhattan Associates Inc. (NASDAQ: MANH) is providing the following corporate update in response […]
Novan Receives Verbal Guidance from FDA for SB206 and Announces Sato Program Advancement
Per verbal guidance, FDA to consider one additional pivotal trialFDA-generated minutes expected on or before May 1, 2020Sato Pharmaceutical to […]
